From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource
about
MalaCards: an integrated compendium for diseases and their annotationA meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokineticsPharmacogenomics knowledge for personalized medicinePharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligandsAn ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-careToward knowledge support for analysis and interpretation of complex traitsToward semantic modeling of pharmacogenomic knowledge for clinical and translational decision supportMining the pharmacogenomics literature--a survey of the state of the artMuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures.RAvariome: a genetic risk variants database for rheumatoid arthritis based on assessment of reproducibility between or within human populations.Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction.Clinical analysis and interpretation of cancer genome dataAnalyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data.Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.CVE: an R package for interactive variant prioritisation in precision oncology.Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.Non-coding polymorphisms in nucleotide binding domain 1 in ABCC1 gene associate with transcript level and survival of patients with breast cancer.Molecular biomarkers for grass pollen immunotherapy.RhesusBase: a knowledgebase for the monkey research communityDrug2Gene: an exhaustive resource to explore effectively the drug-target relation networkGenomic landscape of metastatic colorectal cancer.A genome-wide integrative study of microRNAs in human liver.BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge.Pathway analysis of genome-wide data improves warfarin dose prediction.Evolutionary Diagnosis of non-synonymous variants involved in differential drug response.SASD: the Synthetic Alternative Splicing Database for identifying novel isoform from proteomics.Pathway-based Biomarkers for Breast Cancer in Proteomics.Low frequency variants, collapsed based on biological knowledge, uncover complexity of population stratification in 1000 genomes project data.Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.Personal genomes, quantitative dynamic omics and personalized medicineVaDE: a manually curated database of reproducible associations between various traits and human genomic polymorphisms.EPMA position paper in cancer: current overview and future perspectives.Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCXBioinformatic Resources of microRNA Sequences, Gene Targets, and Genetic Variation.KNOWLEDGE DRIVEN BINNING AND PHEWAS ANALYSIS IN MARSHFIELD PERSONALIZED MEDICINE RESEARCH PROJECT USING BIOBINUsing ODIN for a PharmGKB revalidation experiment.Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202
P2860
Q24570119-76E3B3C7-9D5C-47DF-899A-84075BCE226CQ24602122-077A76F5-E031-48D2-9F75-E1AEF2044483Q24623166-4235A4D3-1081-45E1-8CA4-0623750F8595Q27012807-1E726BBD-7D55-4D8F-BE88-1B32D1E34614Q27136827-B73BD44E-13AD-4C82-9107-E09E52807765Q28538389-DC724AAF-DBB2-4479-93C3-CC600D9F9A69Q28658388-7F153A90-8E27-4933-99DD-F00E88548E6BQ28661907-2C5687E4-6EC0-4AD0-94D3-2F39CE2E7B75Q28728833-C059905E-BD4D-40B6-A188-8A524386259BQ30432282-92FE29CE-0A1B-442D-83B9-CF0C9B28EEC5Q30486443-19AE0C85-D8A8-4871-989C-2BF6C64B787BQ30571118-8C6AF6C4-C417-4C3C-9D6F-C750F92A055CQ30577213-8CA9DCBB-98A7-4F56-BEA3-64ADE4F76E65Q30617093-45FFD169-E83F-4CE9-A27E-6625AEDBA129Q30999121-349F1A40-3905-43B8-87CC-E040AEFFA811Q31114073-16B8BE4D-238D-49F8-A884-25799424EB57Q33730180-44A35752-DF61-4732-BA03-E9DFC7CCF35FQ33760652-6655691A-34A4-4DC5-B75A-2F5487F7BA1AQ33910107-6F281A2F-0EA9-457C-BAA0-BAA8654571CBQ33982601-AA029E18-2585-435A-B662-E39F0E0B402FQ34093047-88050DE7-CB4D-4CC7-84F4-F86524A22BCDQ34298889-B977A991-0297-4709-BA75-E29487CCE452Q34525377-F99808C8-3ADA-435B-A331-BE98A7E93B28Q34568317-D5C3F5EA-449D-48DB-BB16-3E6D142BEA47Q34768681-B6B5E59F-A822-4AC4-BCAA-F78C7D2327DDQ34789942-03DF7295-47EE-4DC0-82EF-22EFDFA4B08EQ34790566-73484A78-A0DD-437C-98EA-C6004224A32EQ35043079-E37A567A-F567-4F2F-929D-93B0CF10CFCCQ35051297-8A253E70-785C-4C27-A83C-AC9737E4689AQ35072971-B9ADAF1C-D82F-4B3A-905F-F602E70963ABQ35079853-704A78EF-D46C-40D3-8E9E-234146FF82A6Q35121473-3536A030-5517-4056-9CDF-C0E1B1744D49Q35195408-A8BB2426-160B-4EF0-A85C-27DAE4E0BEECQ35253318-28F43B0A-20B0-4945-A406-3AC63B75E5FBQ35532215-F0C2730B-3746-402D-9837-E6279971DEE9Q35706472-7EE9DA4A-3122-4E49-9357-F9154EC23CFEQ35800946-C320A391-0273-4C79-822A-A4B52EFA8448Q35896219-FC530E2A-1FB2-4928-A272-1B9814A9025AQ35904823-414089BE-EE85-4774-B546-40AD1BDC9B93Q35908584-81289B9F-353E-49C2-A767-C8A2E7D61BD0
P2860
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@ast
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@en
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@nl
type
label
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@ast
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@en
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@nl
prefLabel
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@ast
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@en
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@nl
P2860
P50
P921
P356
P1476
From pharmacogenomic knowledge ...... macogenomic biomarker resource
@en
P2093
Teri E Klein
Yael Garten
P2860
P304
P356
10.2217/BMM.11.94
P407
P577
2011-12-01T00:00:00Z